Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. The comoany was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is headquartered in London, Canada.
Frequently asked questions
What sector does Sernova Corp (PSH) operate in?
Sernova Corp belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Sernova Corp (PSH) current stock price?
As of the latest data, Sernova Corp stock price is €0.15, with a previous close of €0.14. Sernova Corp gained €0.01 in the last trading session, representing a 7.15% increase.
What is Sernova Corp (PSH) current market capitalization?
Sernova Corp market cap is approximately 49.21 million.
What is Sernova Corp (PSH) Earnings Per Share (EPS)?
The trailing EPS is -€0.10.
Does Sernova Corp (PSH) pay dividends?
No. Sernova Corp does not pay a dividend.
What is Sernova Corp (PSH) beta (volatility) score?
Sernova Corp has a beta of 1.207, suggesting it is more volatile than the market.